Food and Drug Administration - Disqualified/Restricted Lists for Clinical Investigators
The Food and Drug Administration (FDA) maintains a Disqualified/Restricted list for Clinical Investigators to ensure the integrity of clinical trials. This list identifies individuals who have been disqualified or restricted from conducting clinical investigations due to noncompliance with FDA regulations. Being on this list indicates serious concerns, such as issues with data integrity, patient safety, or ethical standards.
Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
234 Entities in Food and Drug Administration - Disqualified/Restricted Lists for Clinical Investigators
| Entity Name | Entity Type | Effective Date | Status |
|---|---|---|---|
Lamphier Timothy A | Individual | Feb 14, 1979 | active |
Lapolla Anthony | Individual | May 5, 1969 | active |
Lippmann Maurice | Individual | Nov 5, 1984 | active |
Saadeh Ghandi M | Individual | Jul 27, 2011 | active |
Lowe Leo | Individual | Oct 18, 1966 | active |
Marker Howard W | Individual | Oct 8, 2009 | active |
Bushnell Walter J | Individual | Sep 16, 1988 | active |
Candal Francisco J | Individual | Mar 29, 2012 | active |
Caruso Walter A | Individual | Jul 28, 1988 | active |
Chaplan Abraham A | Individual | Feb 28, 1979 | active |
FAQs
Why is compliance with Food and Drug Administration - Disqualified/Restricted List for Clinical Investigators necessary?
The Food and Drug Administration (FDA) Disqualified/Restricted List for Clinical Investigators is crucial for maintaining high standards in clinical trials. this list identifies researchers who may not meet the requirements set by the fda. it is vital for compliance professionals to understand why adherence to this list is necessary.
Which companies should comply with Food and Drug Administration - Disqualified/Restricted List for Clinical Investigators?
The Food and Drug Administration (FDA) disqualified/restricted list for clinical investigators impacts companies in the pharmaceutical, biotechnology, and medical device industries. These organizations must comply to ensure that clinical trials are conducted by qualified individuals. Compliance helps protect patient safety, maintains data integrity, and ensures that products meet regulatory standards before reaching the market.
APIs
Data License
Solutions
Pricing
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.